AVENUE THERAPEUTICS, INC. Quarterly Common Stock, Shares, Outstanding from Q4 2016 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Avenue Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2016 to Q3 2024.
  • Avenue Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 1.6M shares, a 82.1% decline year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 1.6M -7.36M -82.1% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 1.19M -6.73M -85% Jun 30, 2024 10-Q 2024-08-09
Q1 2024 590K -6.24M -91.4% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 341K -4.43M -92.9% Dec 31, 2023 10-Q 2024-11-14
Q3 2023 8.96M +7.48M +505% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 7.92M -14.2M -64.2% Jun 30, 2023 10-Q 2023-08-11
Q1 2023 6.83M -15.3M -69.2% Mar 31, 2023 10-Q 2023-05-12
Q4 2022 4.77M +3.37M +240% Dec 31, 2022 10-K 2024-03-18
Q3 2022 1.48M -15.3M -91.2% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 22.1M +5.39M +32.2% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 22.1M +5.39M +32.2% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 1.41M -15.3M -91.6% Dec 31, 2021 10-K 2023-03-31
Q3 2021 16.8M +45.9K +0.27% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 16.7M +45.3K +0.27% Jun 30, 2021 10-Q 2021-08-16
Q1 2021 16.7M +65.3K +0.39% Mar 31, 2021 10-Q 2021-05-17
Q4 2020 16.7M +65.6K +0.39% Dec 31, 2020 10-K 2022-03-25
Q3 2020 16.7M +86.4K +0.52% Sep 30, 2020 10-Q 2020-11-04
Q2 2020 16.7M +143K +0.86% Jun 30, 2020 10-Q 2020-08-14
Q1 2020 16.7M +126K +0.76% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 16.7M +6.01M +56.4% Dec 31, 2019 10-K 2021-03-31
Q3 2019 16.7M +6M +56.3% Sep 30, 2019 10-Q 2019-11-13
Q2 2019 16.6M +6.01M +56.9% Jun 30, 2019 10-Q 2019-08-14
Q1 2019 16.6M +6.01M +56.9% Mar 31, 2019 10-Q 2019-05-13
Q4 2018 10.7M +403K +3.92% Dec 31, 2018 10-K 2020-03-30
Q3 2018 10.7M +397K +3.87% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 10.6M +513K +5.11% Jun 30, 2018 10-Q 2018-08-14
Q1 2018 10.6M +528K +5.26% Mar 31, 2018 10-Q 2018-05-03
Q4 2017 10.3M +7.01M +215% Dec 31, 2017 10-K 2019-03-12
Q3 2017 10.3M Sep 30, 2017 10-Q 2017-11-09
Q2 2017 10M Jun 30, 2017 10-Q 2017-08-11
Q1 2017 10M Mar 31, 2017 10-Q 2017-05-12
Q4 2016 3.26M Dec 31, 2016 10-K 2018-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.